Ultrasound-derived pelvic floor parameters and their association with functional impairment in gynecologic cancer survivors: a retrospective cohort study - Scorecard - MDSpire
Advertisement
Ultrasound-derived pelvic floor parameters and their association with functional impairment in gynecologic cancer survivors: a retrospective cohort study
Clinical Scorecard: Association of Pelvic Floor Ultrasound Metrics with Functional Limitations in Survivors of Gynecologic Cancer: A Retrospective Cohort Analysis
At a Glance
Category
Detail
Condition
Pelvic Floor Dysfunction (PFD) in Gynecologic Cancer Survivors
Key Mechanisms
Structural and functional changes due to cancer treatments, including radiotherapy and surgery.
Target Population
Survivors of cervical, endometrial, and ovarian cancer.
Care Setting
Tertiary oncology facility.
Key Highlights
PFD is a common complication in gynecologic cancer survivors.
Ultrasound metrics correlate with functional impairment and symptom burden.
Radiotherapy is associated with decreased pelvic floor muscle thickness and mobility.
Guideline-Based Recommendations
Diagnosis
Use of Pelvic Floor Distress Inventory-20 (PFDI-20) for assessing symptom burden.
Management
Consider pelvic floor ultrasound for objective assessment of pelvic floor integrity.
Monitoring & Follow-up
Regular follow-up assessments for functional impairments in gynecologic cancer survivors.
Risks
Increased pelvic organ descent and functional impairment associated with radiotherapy.
Patient & Prescribing Data
Female survivors of cervical, endometrial, and ovarian cancer, aged 18 and older.
Patients receiving radiotherapy showed higher PFDI-20 scores compared to those who underwent surgery without radiotherapy.
Clinical Best Practices
Utilize objective imaging techniques like pelvic floor ultrasound for evaluating PFD.
